|
The Pharmaceutical Journal |
Products |
|
AnnouncementsResponsibility for the Asacol (mesalazine) range of tablets, suppositories and foam enemas will be transferred from GlaxoSmithKline to Procter & Gamble from 1 June. The contact details for David Begg Associates, providers of Qualified Person training (PJ, 9 March, p345), have changed to Miss E. Darbyshire, QP Administrator, David Begg Associates Ltd, The Georgian House, 22–24 West End, Kirkbymoorside, York YO62 6AF (tel 01751 432999, fax 01751 432450, e-mail qp@david-begg-associates.com). |
Home | Journals | News | Notice-board | Search | Jobs Classifieds | Site
Map | Contact us
©The Pharmaceutical Journal